retatrutide parkinson clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Parkinson's disease drug therapies in

Less commonly, alopecia areata, traction alopecia, diffuse unpatterned alopecia, or an inflammatory or scarring disorder may be responsible

Approximately 80% of lung cancer cases are classified as NSCLC, of which about 75% have nonsquamous histology

The use of semaglutide is carefully managed and prescribed by our experienced healthcare providers

If fatigue , medication tolerance , or persistent GI distress has made pharmaceutical GLP-1 drugs unworkable, a probiotic approach offers a fundamentally different mechanism with a much milder side effect profile

In medical terms, a half-life is the amount of time it takes for the concentration of a substance in your body to reduce by exactly half

Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway